Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D. L. Stroyakovsky"'
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 63-68 (2022)
The theoretical rationale for intensification of chemotherapy (CT) has become a basis for using of high-dose chemotherapy and for reducing of intervals between courses. At the same time, the toxic effect of cytostatics on bone marrow is one of the mo
Externí odkaz:
https://doaj.org/article/6325bae61da34ab1ab607da6c5ebb6fb
Autor:
N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 100-109 (2019)
Background: Several studies show that the combination chemotherapy with ramucirumab allows to improve the treatment results of advanced gastric cancer (GC). Irinotecan with fluoropyrimidines is own of the second line chemotherapy options for these pa
Externí odkaz:
https://doaj.org/article/ea3ef83961b9437bae7fe589b286537d
Autor:
E. V. Lubennikova, I. P. Ganshina, A. N. Lud, D. V. Komov, I. V. Kolyadina, Y. V. Vishnevskaya, I. K. Vorotnikov, D. L. Stroyakovsky, N. A. Savelov, V. F. Semiglazov, А. G. Manikhas, А. V. Osheychik, T. B. Strelnikova, K. R. Zeynalova, L. G. Zhukova
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 40-45 (2017)
The HannaH study showed that neoadjuvante-adjuvant subcutaneous and intravenous trastuzumab have similar efficacy and tolerability in patients with early HER2-positive breast cancer. The analysis of the results of the subcutaneous and intravenous tra
Externí odkaz:
https://doaj.org/article/0afd2a86a60849f9a99f21aaed7bb676